skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Giant Magnetoresistance (GMR) sensors for 0.35µm CMOS technology sub-mA current sensing
Giant Magnetoresistance (GMR) sensors for 0.35µm CMOS technology sub-mA current sensing
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Giant Magnetoresistance (GMR) sensors for 0.35µm CMOS technology sub-mA current sensing

de Marcellis, Andrea ; Reig, C. ; Cubells, M. D. ; Madrenas, J. ; Cardoso, F. ; Cardoso, S. ; Freitas, P. P.

IEEE SENSORS 2014 Proceedings, 2014, p.444-447

IEEE

Texto completo disponível

Citações Citado por
2
Nursing Clinical Documentation System Structured on NANDA-I, NOC, and NIC Classification Systems
Nursing Clinical Documentation System Structured on NANDA-I, NOC, and NIC Classification Systems
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Nursing Clinical Documentation System Structured on NANDA-I, NOC, and NIC Classification Systems

Peres, Heloisa Helena C ; de Almeida Lopes M da Cruz, Diná ; Tellez, Michelle ; de Cassia Gengo e Silva, Rita ; dos S Diogo, Regina Celia ; Ortiz, Diley Cardoso F ; Ortiz, Dóris R

Studies in health technology and informatics, 2015, Vol.216, p.943-943 [Periódico revisado por pares]

Netherlands

Texto completo disponível

Citações Citado por
3
Sequential administration of sunitinib (SU) and docetaxel (D) in women with advanced breast cancer (ABC): an exploratory evaluation
Sequential administration of sunitinib (SU) and docetaxel (D) in women with advanced breast cancer (ABC): an exploratory evaluation
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Sequential administration of sunitinib (SU) and docetaxel (D) in women with advanced breast cancer (ABC): an exploratory evaluation

Mariani, G. ; Cardoso, F. ; Besse-Hammer, T. ; Viganò, L. ; Liljegren, A. ; Verkh, L. ; Huang, X. ; Giorgetti, C. ; Bergh, J. ; Gianni, L.

JOURNAL OF CLINICAL ONCOLOGY, 2008, Vol.26 (15_suppl), p.14534-14534 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab
Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

Jerusalem, G. H. ; Dieras, V. ; Cardoso, F. ; Bergh, J. ; Fasolo, A. ; Rorive, A. ; Manlius, C. ; Pylvaenaeinen, I. ; Sahmoud, T. ; Gianni, L.

JOURNAL OF CLINICAL ONCOLOGY, 2008, Vol.26 (15_suppl), p.1057-1057 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Multidimensional independent component analysis
Multidimensional independent component analysis
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Multidimensional independent component analysis

Cardoso, J.-F.

Proceedings of the 1998 IEEE International Conference on Acoustics, Speech and Signal Processing, ICASSP '98 (Cat. No.98CH36181), 1998, Vol.4, p.1941-1944 vol.4

IEEE

Texto completo disponível

Citações Citado por
6
Neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
Neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study

Kummel, S ; Schmid, P ; Harbeck, N ; Takahashi, M ; Untch, M ; Boileau, JF ; Cortes, J ; McArthur, H ; Dent, R ; O'Shaughnessy, J ; Pusztai, L ; Foukakis, T ; Park, YH ; Hui, R ; Cardoso, F ; Denkert, C ; Zhu, Y ; Pan, W ; Karantza, V ; Fasching, P

BREAST, 2023, Vol.68, p.S63 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study
Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early TNBC: Surgical Outcomes from the Phase 3 KEYNOTE-522 Study

Kummel, S ; Schmid, P ; Harbeck, N ; Takahashi, M ; Untch, M ; Boileau, JF ; Cortes, J ; McArthur, H ; Dent, R ; O'Shaughnessy, J ; Pusztai, L ; Foukakis, T ; Park, YH ; Hui, RN ; Cardoso, F ; Denkert, C ; Zhu, YL ; Pan, W ; Karantza, V ; Fasching, PA

ANNALS OF SURGICAL ONCOLOGY, 2023, Vol.30 (SUPPL 2), p.S295 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study
Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study

Schmid, P ; Cortes, J ; Dent, RA ; Pusztai, L ; McArthur, HL ; Kummel, S ; Denkert, C ; Park, YH ; Hui, R ; Harbeck, N ; Takahashi, M ; Foukakis, T ; Reynier, MAM ; Ferreira, MIR ; Im, SA ; Cardoso, F ; Ding, Y ; Pan, W ; Tryfonidis, KE ; O'Shaughnessy, J

ANNALS OF ONCOLOGY, 2023, Vol.34, p.S1257 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Does baseline health-related quality of life scores (QLQC30) add prognostic value beyond clinical measures and improve prognostic accuracy in cancer RCTs?
Does baseline health-related quality of life scores (QLQC30) add prognostic value beyond clinical measures and improve prognostic accuracy in cancer RCTs?
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Does baseline health-related quality of life scores (QLQC30) add prognostic value beyond clinical measures and improve prognostic accuracy in cancer RCTs?

Machingura, A ; Musoro, J ; Taye, M ; Ringash, J ; Pe, M ; Coens, C ; Martinelli, F ; Tu, DS ; Basch, E ; Brandberg, Y ; Groenvold, M ; Eggermont, A ; Cardoso, F ; Van Meerbeeck, J ; van der Graaf, WTA ; Taphoorn, M ; Reijneveld, JC ; Soffietti, R ; Sloan, J ; Velikova, G ; Flechtner, H ; Bottomley, A

QUALITY OF LIFE RESEARCH, 2022, Vol.31, p.S83 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Event-free survival by residual cancer burden after neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for early TNBC: Exploratory analysis from KEYNOTE-522
Event-free survival by residual cancer burden after neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for early TNBC: Exploratory analysis from KEYNOTE-522
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Event-free survival by residual cancer burden after neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for early TNBC: Exploratory analysis from KEYNOTE-522

Pusztai, L ; Denkert, C ; O'Shaughnessy, J ; Cortes, J ; Dent, RA ; McArthur, HL ; Kuemmel, S ; Bergh, JCS ; Park, YH ; Hui, RN ; Harbeck, N ; Takahashi, M ; Untch, M ; Fasching, PA ; Cardoso, F ; Zhu, YL ; Pan, W ; Tryfonidis, K ; Schmid, P

JOURNAL OF CLINICAL ONCOLOGY, 2022, Vol.40 (16) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (181)

Data de Publicação 

De até
Refinar
  1. Antes de1997  (24)
  2. 1997Até2002  (44)
  3. 2003Até2008  (92)
  4. 2009Até2015  (192)
  5. Após 2015  (77)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (424)
  2. Português  (3)
  3. Russo  (2)
  4. Japonês  (2)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.